Works matching IS 0274726X AND DT 2022 AND VI 43 AND IP 3
Results: 8
U.S. Chlamydia Rates Continue to Climb.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
Herpes Vaccine Could Be Available by 2030: New approach uses mRNA.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
STI Rates Increasing, but Efficient Testing Can Help: California leads with at-home test kits.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
Accessing Hormonal Contraception by Pharmacy Prescriptions.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
Disrupted Contraceptive Care Hurt Disadvantaged Patients the Most.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
A Tale of Two Times: Contraceptive Care in the COVID-19 Pandemic.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
New Research Highlights Effect of COVID-19 on Contraceptive Care.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article
Researchers Highlight Isolation, Stigma of Abortion Providers in the South.
- Published in:
- Contraceptive Technology Update, 2022, v. 43, n. 3, p. 1
- Publication type:
- Article